Parallel Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Hold
0
-$27 3345
2023
Q3
Sell
-2
Closed -$140 3318
2023
Q2
$122 Buy
+2
New +$146 ﹤0.01% 3273
2023
Q1
Sell
-3
Closed -$343 3374
2022
Q4
$443 Hold
3
﹤0.01% 3050
2022
Q3
$0 Buy
+3
New +$339 ﹤0.01% 3153
2022
Q2
Sell
-2
Closed -$155 3012
2022
Q1
$0 Sell
2
-6
-75% -$792 ﹤0.01% 2985
2021
Q4
$2K Sell
8
-4
-33% -$944 ﹤0.01% 2663
2021
Q3
$3K Buy
12
+7
+140% +$2K ﹤0.01% 2545
2021
Q2
$2K Buy
5
+1
+25% +$396 ﹤0.01% 2529
2021
Q1
$2K Sell
4
-12
-75% -$5.91K ﹤0.01% 2443
2020
Q4
$9K Sell
16
-4
-20% -$2.54K ﹤0.01% 1813
2020
Q3
$14K Buy
20
+5
+33% +$3.9K ﹤0.01% 1577
2020
Q2
$11K Buy
15
+9
+150% +$6.79K ﹤0.01% 1670
2020
Q1
$3K Sell
6
-1
-14% -$975 ﹤0.01% 2010
2019
Q4
$8K Buy
+7
New +$7.61K ﹤0.01% 1798
2019
Q3
Hold
0
2398
2019
Q2
Sell
-2
Closed -$3.46K 2320
2019
Q1
$3K Buy
2
+1
+100% +$1.76K ﹤0.01% 1942
2018
Q4
$0 Hold
1
﹤0.01% 2117
2018
Q3
$3K Sell
1
-1
-50% -$2.07K ﹤0.01% 1871
2018
Q2
$4K Hold
2
﹤0.01% 1650
2018
Q1
$4K Buy
2
+1
+100% +$2.54K ﹤0.01% 1608
2017
Q4
$2K Hold
1
﹤0.01% 1827
2017
Q3
$2K Hold
1
﹤0.01% 1821
2017
Q2
$1K Buy
+1
New +$1.21K ﹤0.01% 1968

Other funds holding BLUE

Parallel Advisors's BLUE Position: Q4 2023 in Review

Parallel Advisors held its bluebird bio (BLUE) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3345.

Parallel Advisors first reported a position in BLUE in Q2 2017 and has held it in 21 quarters since. The position peaked at $14K in Q3 2020. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Parallel Advisors held 0 shares of bluebird bio worth $0 as of Q4 2023.
  • Parallel Advisors left its bluebird bio share count unchanged in Q4 2023.
  • bluebird bio made up ﹤0.01% of Parallel Advisors's portfolio in Q4 2023, its #3345 holding.
  • Parallel Advisors first reported a position in bluebird bio in Q2 2017 and has held it in 21 quarters since.
  • Parallel Advisors's bluebird bio position peaked at $14K in Q3 2020.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.